Exploratory randomised double-blind controlled trial of breast milk fortifier with and without long chain polyunsaturated fatty acid (LCPUFA) supplementation on body composition in preterm infants

ISRCTN ISRCTN59878178
DOI https://doi.org/10.1186/ISRCTN59878178
Secondary identifying numbers N/A
Submission date
06/09/2005
Registration date
13/09/2005
Last edited
30/08/2007
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Neonatal Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Prof Neena Modi
Scientific

Imperial College London
Chelsea & Westminster Hospital
369 Fulham Road
London
SW10 9NH
United Kingdom

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeNot Specified
Scientific title
Study objectivesBreast milk fortifier containing LCPUFA has a measurable effect upon body composition at term when compared with non-LCPUFA supplemented fortifier
Ethics approval(s)Not provided at time of registration.
Health condition(s) or problem(s) studiedPreterm infants
InterventionInfants will receive maternal +/- donor breast milk; should breast milk fortifier be indicated in accordance with normal clinical practice, infants will be randomised to receive standard fortifier or LCPUFA supplemented fortifier.
Intervention typeOther
Primary outcome measureBody composition at age term-equivalent
Secondary outcome measuresGrowth, metabolic profile, intrahepatocellular lipid content, brain growth and development, neurological examination
Overall study start date01/08/2005
Completion date30/06/2006

Eligibility

Participant type(s)Patient
Age groupNeonate
SexNot Specified
Target number of participants120 of whom 42 will be randomised
Key inclusion criteriaInfants born at or below 32 weeks gestational age
Key exclusion criteria1. Major congenital abnormality

2. Mother does not wish to provide breast milk or to use donor milk
3. Baby requires gastrointestinal surgery
Date of first enrolment01/08/2005
Date of final enrolment30/06/2006

Locations

Countries of recruitment

  • England
  • Germany
  • United Kingdom

Study participating centre

Imperial College London
London
SW10 9NH
United Kingdom

Sponsor information

Milupa GmbH, Numico Research (Germany)
Industry

Bahnstrasse 14-30
Friedrichsdorf
61381
Germany

ROR logo "ROR" https://ror.org/00aj77a24

Funders

Funder type

Industry

Numico Research Germany

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan